Translational Regulation by eIFs and RNA Modifications in Cancer

16Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Translation is a fundamental process in all living organisms that involves the decoding of genetic information in mRNA by ribosomes and translation factors. The dysregulation of mRNA translation is a common feature of tumorigenesis. Protein expression reflects the total outcome of multiple regulatory mechanisms that change the metabolism of mRNA pathways from synthesis to degradation. Accumulated evidence has clarified the role of an increasing amount of mRNA modifications at each phase of the pathway, resulting in translational output. Translation machinery is directly affected by mRNA modifications, influencing translation initiation, elongation, and termination or altering mRNA abundance and subcellular localization. In this review, we focus on the translation initiation factors associated with cancer as well as several important RNA modifications, for which we describe their association with cancer.

Cite

CITATION STYLE

APA

Zhang, L., Zhang, Y., Zhang, S., Qiu, L., Zhang, Y., Zhou, Y., … Xie, J. (2022, November 6). Translational Regulation by eIFs and RNA Modifications in Cancer. Genes. NLM (Medline). https://doi.org/10.3390/genes13112050

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free